Literature DB >> 31774192

Identification of the optimal treatment regimen in the presence of missing covariates.

Ying Huang1, Xiao-Hua Zhou2.   

Abstract

Covariates associated with treatment-effect heterogeneity can potentially be used to make personalized treatment recommendations towards best clinical outcomes. Methods for treatment-selection rule development that directly maximize treatment-selection benefits have attracted much interest in recent years, due to the robustness of these methods to outcome modeling. In practice, the task of treatment-selection rule development can be further complicated by missingness in data. Here, we consider the identification of optimal treatment-selection rules for a binary disease outcome when measurements of an important covariate from study participants are partly missing. Under the missing at random assumption, we develop a robust estimator of treatment-selection rules under the direct-optimization paradigm. This estimator targets the maximum selection benefits to the population under correct specification of at least one mechanism from each of the two sets-missing data or conditional covariate distribution, and treatment assignment or disease outcome model. We evaluate and compare performance of the proposed estimator with alternative direct-optimization estimators through extensive simulation studies. We demonstrate the application of the proposed method through a real data example from an Alzheimer's disease study for developing covariate combinations to guide the treatment of Alzheimer's disease.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  augmented inverse probability weighting; biomarker; missing at random; robust; treatment-selection

Mesh:

Year:  2019        PMID: 31774192      PMCID: PMC6954309          DOI: 10.1002/sim.8407

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  22 in total

1.  Causal inference with missing exposure information: Methods and applications to an obstetric study.

Authors:  Zhiwei Zhang; Wei Liu; Bo Zhang; Li Tang; Jun Zhang
Journal:  Stat Methods Med Res       Date:  2013-12-05       Impact factor: 3.021

2.  Subgroup identification from randomized clinical trial data.

Authors:  Jared C Foster; Jeremy M G Taylor; Stephen J Ruberg
Journal:  Stat Med       Date:  2011-08-04       Impact factor: 2.373

3.  Combining biomarkers linearly and nonlinearly for classification using the area under the ROC curve.

Authors:  Youyi Fong; Shuxin Yin; Ying Huang
Journal:  Stat Med       Date:  2016-04-05       Impact factor: 2.373

4.  Identifying optimal biomarker combinations for treatment selection via a robust kernel method.

Authors:  Ying Huang; Youyi Fong
Journal:  Biometrics       Date:  2014-08-14       Impact factor: 2.571

5.  PERFORMANCE GUARANTEES FOR INDIVIDUALIZED TREATMENT RULES.

Authors:  Min Qian; Susan A Murphy
Journal:  Ann Stat       Date:  2011-04-01       Impact factor: 4.028

6.  On Inverse Probability Weighting for Nonmonotone Missing at Random Data.

Authors:  BaoLuo Sun; Eric J Tchetgen Tchetgen
Journal:  J Am Stat Assoc       Date:  2017-12-01       Impact factor: 5.033

7.  FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial.

Authors:  Shuying S Li; Peter B Gilbert; Georgia D Tomaras; Gustavo Kijak; Guido Ferrari; Rasmi Thomas; Chul-Woo Pyo; Susan Zolla-Pazner; David Montefiori; Hua-Xin Liao; Gary Nabel; Abraham Pinter; David T Evans; Raphael Gottardo; James Y Dai; Holly Janes; Daryl Morris; Youyi Fong; Paul T Edlefsen; Fusheng Li; Nicole Frahm; Michael D Alpert; Heather Prentice; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Jaranit Kaewkungwal; Sorachai Nitayaphan; Merlin L Robb; Robert J O'Connell; Barton F Haynes; Nelson L Michael; Jerome H Kim; M Juliana McElrath; Daniel E Geraghty
Journal:  J Clin Invest       Date:  2014-08-08       Impact factor: 14.808

8.  A multiple imputation strategy for sequential multiple assignment randomized trials.

Authors:  Susan M Shortreed; Eric Laber; T Scott Stroup; Joelle Pineau; Susan A Murphy
Journal:  Stat Med       Date:  2014-06-11       Impact factor: 2.373

9.  Characterizing expected benefits of biomarkers in treatment selection.

Authors:  Ying Huang; Eric B Laber; Holly Janes
Journal:  Biostatistics       Date:  2014-09-03       Impact factor: 5.899

10.  On Estimation of Optimal Treatment Regimes For Maximizing t-Year Survival Probability.

Authors:  Runchao Jiang; Wenbin Lu; Rui Song; Marie Davidian
Journal:  J R Stat Soc Series B Stat Methodol       Date:  2016-09-02       Impact factor: 4.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.